Track topics on Twitter Track topics that are important to you
Speaker of the House Nancy Pelosi recently unveiled a radical plan that would restrict and fundamentally change how patients access medicines in the United States. It would threaten our country’s global leadership in developing innovative, lifesaving treatments and cures and force patients to face the uncertainty of a health care system where the government sets prices for critical medicines and import foreign determinations of the value of medicines. Such a system allows the government to dictate which disease areas are worthy of future research and represents a de facto nationalization of the innovative biopharmaceutical industry.
Original Article: Four reasons why the radical Pelosi Plan is the wrong approachNEXT ARTICLE
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...